Jianfeng Xie: Clinical Trials

13 trials sponsored by Jianfeng Xie, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 5 unknown, 1 not yet recruiting, 1 recruiting. 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Unknown 1
Phase 41Not yet recruiting 1

Follow Jianfeng Xie: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nafamostat Mesylate Versus Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in Sepsis-Associated Acute Kidney Injury
Citrate anticoagulation, Nafamostat Mesylate - Sepsis, Acute Kidney Injury
Phase 4Not yet recruitingJianfeng Xie11622026-06-102026-06-03
Influenza A-associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit in China
IPA and non-IPA groups - ICU, Invasive Pulmonary Aspergillosis
CompletedJianfeng Xie5422025-11-012026-01-09
Epidemiological Investigation of Central Venous Catheter-related Bloodstream Infections in Icus in China
CLABSI - Central Line Associated Bloodstream Infection
RecruitingJianfeng Xie18462025-06-082025-11-28
The Effect and Mechanism of lncRNA NBR2 Regulating Endothelial Pyroptosis by Targeting GSDMD in Sepsis
the levels of pyroptosis - Sepsis
UnknownJianfeng Xie1002020-05-222020-06-11
Shenfu Injection Improves Arterial Vascular Reactivity
shenfu injection - Septic Shock, Shenfu
Phase 2 / Phase 3UnknownJianfeng Xie262018-12-012018-11-21
Effects of Different Driving Pressure on Lung Stress, Strain and Mechanical Power in Patients With Moderate to Severe ARDS
ARDS, Driving Pressure
UnknownJianfeng Xie122017-12-012018-08-06
Long-term Quality of Life Among Survivors of Sepsis in China Assessed by EQ-5D
Sepsis
CompletedJianfeng Xie13682015-11-012019-07-26
Epidemiology of Sepsis in China
Observational study, none intervention - Sepsis
CompletedJianfeng Xie20002015-11-012016-02-17
Dynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis Patients
Sepsis
CompletedJianfeng Xie852014-09-012018-08-21
ARDS Prediction Score in Critically Ill Patients in China
ARDS, Septic Shock
CompletedJianfeng Xie6982014-03-012016-06-28
The Classification of Difficult Weaning and the Predictive Value of Relative Factors for Difficult Weaning
weaning - Intensive Care Medicine, Mechanical Ventilation
UnknownJianfeng Xie1102012-06-012015-07-02
Antimicrobial Stewardship Reduces MDRO Isolates in Critically Ill Patients
Sepsis
CompletedJianfeng Xie9782012-06-012014-05-01
Diagnostic and Prognostic Value of Combination Biomarkers in the Critically Ill Patient With Sepsis.
Diagnostic and Predictive Value
UnknownJianfeng Xie3002012-03-012012-09-18

Conditions studied

Sepsis (6)  ·  Shock, Septic (2)  ·  Acute Kidney Injury (1)  ·  Disease (1)  ·  Invasive Pulmonary Aspergillosis (1)  ·  Sprains and Strains (1)

Interventions

Observation (1)  ·  Shen-Fu (1)  ·  Weaning (1)  ·  nafamostat (1)

Countries

China (10)

Top investigators

Yang Yi, Ph.D. (2)  ·  Haibo Qiu, Dr (1)  ·  Yingzi Huang (1)

Results publications

PMID 27887595, PMID 27958229, PMID 30813927, PMID 31804299